CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 75 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61 | -84.4% | 89,270 | -72.6% | 0.00% | -100.0% |
| Q2 2023 | $391 | -16.3% | 326,170 | -18.3% | 0.00% | 0.0% |
| Q1 2023 | $467 | +44.6% | 399,270 | -2.4% | 0.00% | – |
| Q4 2022 | $323 | -99.9% | 409,170 | +4.7% | 0.00% | -100.0% |
| Q3 2022 | $473,000 | +35.1% | 390,770 | +2.7% | 0.00% | – |
| Q2 2022 | $350,000 | +400.0% | 380,470 | +868.1% | 0.00% | – |
| Q1 2022 | $70,000 | -96.1% | 39,300 | -95.6% | 0.00% | -100.0% |
| Q3 2021 | $1,804,000 | -72.7% | 888,501 | -53.2% | 0.00% | -75.0% |
| Q2 2021 | $6,606,000 | +275.1% | 1,898,351 | +91.9% | 0.01% | +300.0% |
| Q1 2021 | $1,761,000 | +7904.5% | 989,096 | +4548.7% | 0.00% | – |
| Q4 2020 | $22,000 | -60.0% | 21,277 | -76.9% | 0.00% | – |
| Q1 2020 | $55,000 | +10.0% | 92,300 | +79.8% | 0.00% | – |
| Q2 2019 | $50,000 | -51.0% | 51,333 | -28.2% | 0.00% | – |
| Q1 2019 | $102,000 | +29.1% | 71,533 | -6.0% | 0.00% | – |
| Q4 2018 | $79,000 | -21.0% | 76,133 | +30.5% | 0.00% | – |
| Q3 2018 | $100,000 | – | 58,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 198,632 | $232,399 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 452,561 | $529 | 0.05% |
| Wealth Advisory Solutions, LLC | 155,850 | $182,345 | 0.05% |
| CHELSEA COUNSEL CO | 81,300 | $95,121 | 0.05% |
| Horst & Graben Wealth Management LLC | 75,722 | $89,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $58,500 | 0.01% |
| Pasadena Private Wealth, LLC | 10,965 | $12,829 | 0.00% |
| Jump Financial, LLC | 66,143 | $77,387 | 0.00% |
| Lighthouse Investment Partners, LLC | 36,126 | $42,267 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 75,188 | $87,970 | 0.00% |